The central city of Da Nang has granted an investment licence to Da Nang Pharmaceutical joint-stock company (Danapha)'s first nano-technology and biotech project.

The city said the project is the third in its 1,010-hectare Hi-Tech Park in Hoa Vang district, 20km west of the city. Danapha joins two Japanese companies – Tokyo Keiki Precision Technology Inc and Niwa Foundry, with a total investment of USD 62 million. They are the first domestic investor since the park opened in 2013.

Da Nang granted a licence for Danapha to develop a cutting edge pharmaceutical project in Hi-tech Park. (Source: Internet)

As scheduled, Danapha will invest VND1.5 trillion (USD67 million) to build a complex dedicated to Nano Technology/Bio Technology and Hi-tech research and development centre. The projects will be built on an area of 7.7ha in three phases between 2017-2021. The complex plans to produce 1 billion tablets and 100 million units of injectable drugs per year from 2017-2018.

Danapha also started an Asian alternative medicine production factory in the Ho Khanh Industrial Park in 2009 – as its first plant meeting GMP-WHO (good manufacturing practices as recommended by the World Health Organization) standards.

Danapha, listed on the Hanoi Stock Exchange as DNP, is one of the few enterprises in the central city investing in technological research and production. It has completed research on a nanotechnology-based cancer injection that could lead to cheaper cancer treatments in the central region.